Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
December 12, 2024 11:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Investors in Edwards Lifesciences Corporation (NYSE: EW) contend that the medical device giant misled them about the growth prospects of its core...
AstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens Berman
December 11, 2024 22:21 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- AstraZeneca PLC (NASDAQ: AZN) is facing a significant crisis in China as authorities there investigate the company for alleged fraud, illegal drug...
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
December 09, 2024 19:51 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling...
Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud – Hagens Berman
December 09, 2024 13:42 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of...
Toronto-Dominion Bank (TD) Subsidiaries Plead Guilty to Violating Bank Secrecy Act and Conspiracy to Commit Money Laundering – Hagens Berman
December 09, 2024 13:41 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- On October 23, 2024, Moody’s downgraded the long-term ratings of The Toronto-Dominion Bank (NYSE: TD) and its U.S. subsidiaries in response to the...
Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman
December 09, 2024 13:32 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Humacyte, a biotechnology company focused on regenerative medicine, is now facing an investor class action alleging that the company misled investors...
Zeta Global Holdings (ZETA) Faces Investor Class Action Alleging Revenue Round-Tripping & Improper Use of Consent Farms – Hagens Berman
December 09, 2024 13:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Digital marketing giant Zeta Global Holdings Corp. (NYSE: ZETA) is now facing a class action lawsuit from aggrieved investors who claim they were...
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi – Hagens Berman
December 09, 2024 13:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they...
Investors Claim Customers Bancorp (CUBI) Concealed Regulatory Risks - Hagens Berman
December 09, 2024 13:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Customer Bancorp is now the target of a securities class action, alleging that the company and certain of its top executives misled investors about...
Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues – Hagens Berman
December 09, 2024 13:24 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), the automation technology company, is facing a securities fraud class action lawsuit after its stock price plummeted...